Serotonin-secreting enteroendocrine cells respond via diverse mechanisms to acute and chronic changes in glucose availability

Nutrition and Metabolism

Volumn 12, Issue 1, 2015, Pages

  Zelkas, Leah ^a   Raghupathi, Ravi ^a,b   Lumsden, Amanda L ^a,b   Martin, Alyce M ^a,b   Sun, Emily ^a,b   Spencer, Nick J ^a   Young, Richard L ^b,c   Keating, Damien J ^a,b  

^a FLINDERS UNIVERSITY   (Australia)

^b SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Enteroendocrine; Glucose; Serotonin

Indexed keywords

CALCIUM ION; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 3; SEROTONIN;

AMPEROMETRY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM IMAGING; CALCIUM TRANSPORT; CELL FUNCTION; CONTROLLED STUDY; ENTEROENDOCRINE CELL; EXOCYTOSIS; GUINEA PIG; IMAGING; MOUSE; NONHUMAN; PRIMARY CULTURE; REAL TIME POLYMERASE CHAIN REACTION; SEROTONIN METABOLISM; SEROTONIN RELEASE; TRANSCRIPTION REGULATION;

EID: 84949768732     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/s12986-015-0051-0     Document Type: Article

References (37)

1. Cho HJ, Robinson ES, Rivera LR, McMillan PJ, Testro A, Nikfarjam M, et al. Glucagon-like peptide 1 and peptide YY are in separate storage organelles in enteroendocrine cells. Cell Tissue Res. 2014;357(1):63-9. doi: 10.1007/s00441-014-1886-9.
2. Scott RV, Tan TM, Bloom SR. Can Bayliss and Starling gut hormones cure a worldwide pandemic? J Physiol. 2014;592(Pt 23):5153-67. doi: 10.1113/jphysiol.2014.272955.
3. Erspamer V. Pharmacology of indole-alkylamines. Pharmacol Rev. 1954;6(4):425-87.
4. Mawe GM, Hoffman JM. Serotonin signalling in the gut - functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2013;10(8):473-86. doi: 10.1038/nrgastro.2013.105.
5. Spencer NJ, Sia TC, Brookes SJ, Costa M, Keating DJ. CrossTalk opposing view: 5-HT is not necessary for peristalsis. J Physiol. 2015;593(15):3229-31. doi: 10.1113/JP270183.
6. Sumara G, Sumara O, Kim JK, Karsenty G. Gut-derived serotonin is a multifunctional determinant to fasting adaptation. Cell Metab. 2012;16(5):588-600. doi: 10.1016/j.cmet.2012.09.014.
7. Crane JD, Palanivel R, Mottillo EP, Bujak AL, Wang H, Ford RJ, et al. Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis. Nat Med. 2015;21(2):166-72. doi: 10.1038/nm.3766.
8. Young RL, Lumsden AL, Keating DJ. Gut Serotonin Is a Regulator of Obesity and Metabolism. Gastroenterology. 2015;149(1):253-5. doi: 10.1053/j.gastro.2015.05.020.
9. Pappenheimer JR. On the coupling of membrane digestion with intestinal absorption of sugars and amino acids. Am J Physiol. 1993;265(3 Pt 1):G409-17.
10. Raybould HE, Glatzle J, Robin C, Meyer JH, Phan T, Wong H, et al. Expression of 5-HT3 receptors by extrinsic duodenal afferents contribute to intestinal inhibition of gastric emptying. Am J Physiol Gastrointest Liver Physiol. 2003;284(3):G367-72. doi: 10.1152/ajpgi.00292.2001.
11. Savastano DM, Carelle M, Covasa M. Serotonin-type 3 receptors mediate intestinal Polycose- and glucose-induced suppression of intake. Am J Physiol Regul Integr Comp Physiol. 2005;288(6):R1499-508. doi: 10.1152/ajpregu.00745.2004.
12. Li Y, Hao Y, Zhu J, Owyang C. Serotonin released from intestinal enterochromaffin cells mediates luminal non-cholecystokinin-stimulated pancreatic secretion in rats. Gastroenterology. 2000;118(6):1197-207.
13. Zhu JX, Zhu XY, Owyang C, Li Y. Intestinal serotonin acts as a paracrine substance to mediate vagal signal transmission evoked by luminal factors in the rat. J Physiol. 2001;530(Pt 3):431-42. doi:PHY-11439 [pii].
14. Freeman SL, Bohan D, Darcel N, Raybould HE. Luminal glucose sensing in the rat intestine has characteristics of a sodium-glucose cotransporter. Am J Physiol Gastrointest Liver Physiol. 2006;291(3):G439-45. doi: 10.1152/ajpgi.00079.2006.
15. Raybould HE. Sensing of glucose in the gastrointestinal tract. Auton Neurosci. 2007;133(1):86-90. doi: 10.1016/j.autneu.2007.01.006.
16. Kim M, Cooke HJ, Javed NH, Carey HV, Christofi F, Raybould HE. D-glucose releases 5-hydroxytryptamine from human BON cells as a model of enterochromaffin cells. Gastroenterology. 2001;121(6):1400-6.
17. Raghupathi R, Duffield MD, Zelkas L, Meedeniya A, Brookes SJ, Sia TC, et al. Identification of unique release kinetics of serotonin from guinea-pig and human enterochromaffin cells. J Physiol. 2013;591(Pt 23):5959-75. doi: 10.1113/jphysiol.2013.259796.
18. Mackenzie KD, Duffield MD, Peiris H, Phillips L, Zanin MP, Teo EH, et al. Huntingtin-associated protein 1 regulates exocytosis, vesicle docking, readily releasable pool size and fusion pore stability in mouse chromaffin cells. J Physiol. 2014;592(Pt 7):1505-18. doi: 10.1113/jphysiol.2013.268342.
19. Keating DJ, Dubach D, Zanin MP, Yu Y, Martin K, Zhao YF, et al. DSCR1/RCAN1 regulates vesicle exocytosis and fusion pore kinetics: implications for Down syndrome and Alzheimer's disease. Hum Mol Gen. 2008;17(7):1020-30.
20. Maritzen T, Keating DJ, Neagoe I, Zdebik AA, Jentsch TJ. Role of the vesicular chloride transporter ClC-3 in neuroendocrine tissue. J Neurosci. 2008;28(42):10587-98. doi: 10.1523/JNEUROSCI.3750-08.2008.
21. Zanin MP, Phillips L, Mackenzie KD, Keating DJ. Aging differentially affects multiple aspects of vesicle fusion kinetics. PLoS One. 2011;6(11):e27820. doi: 10.1371/journal.pone.0027820.
22. Keating DJ, Spencer NJ. Release of 5-hydroxytryptamine from the mucosa is not required for the generation or propagation of colonic migrating motor complexes. Gastroenterology. 2010;138(2):659-70. doi: 10.1053/j.gastro.2009.09.020.
23. Spencer NJ, Nicholas SJ, Robinson L, Kyloh M, Flack N, Brookes SJ, et al. Mechanisms underlying distension-evoked peristalsis in guinea pig distal colon: is there a role for enterochromaffin cells? Am J Physiol Gastrointest Liver Physiol. 2011;301(3):G519-27. doi: 10.1152/ajpgi.00101.2011.
24. Peiris H, Raghupathi R, Jessup CF, Zanin MP, Mohanasundaram D, Mackenzie KD, et al. Increased expression of the glucose-responsive gene, RCAN1, causes hypoinsulinemia, beta-cell dysfunction, and diabetes. Endocrinology. 2012;153(11):5212-21. doi: 10.1210/en.2011-2149.
25. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002;30(9):e36.
26. Keating DJ, Winter MA, Hemsley KM, Mackenzie KD, Teo EH, Hopwood JJ, et al. Exocytosis is impaired in mucopolysaccharidosis IIIA mouse chromaffin cells. Neuroscience. 2012;227:110-8. doi: 10.1016/j.neuroscience.2012.09.034.
27. Zanin MP, Mackenzie KD, Peiris H, Pritchard MA, Keating DJ. RCAN1 regulates vesicle recycling and quantal release kinetics via effects on calcineurin activity. J Neurochem. 2013;124(3):290-9. doi: 10.1111/jnc.12086.
28. Pothos EN, Mosharov E, Liu KP, Setlik W, Haburcak M, Baldini G, et al. Stimulation-dependent regulation of the pH, volume and quantal size of bovine and rodent secretory vesicles. J Physiol. 2002;542(Pt 2):453-76.
29. Deane AM, Rayner CK, Keeshan A, Cvijanovic N, Marino Z, Nguyen NQ, et al. The effects of critical illness on intestinal glucose sensing, transporters, and absorption. Crit Care Med. 2014;42(1):57-65. doi: 10.1097/CCM.0b013e318298a8af.
30. Wu T, Bound MJ, Standfield SD, Bellon M, Young RL, Jones KL, et al. Artificial sweeteners have no effect on gastric emptying, glucagon-like peptide-1, or glycemia after oral glucose in healthy humans. Diabetes Care. 2013;36(12):e202-3. doi: 10.2337/dc13-0958.
31. Jackson J, Papadopulos A, Meunier FA, McCluskey A, Robinson PJ, Keating DJ. Small molecules demonstrate the role of dynamin as a bi-directional regulator of the exocytosis fusion pore and vesicle release. Mol Psychiatry. 2015;20(7):810-9. doi: 10.1038/mp.2015.56.
32. Yu Y, Chu PY, Bowser DN, Keating DJ, Dubach D, Harper I, et al. Mice deficient for the chromosome 21 ortholog Itsn1 exhibit vesicle-trafficking abnormalities. Hum Mol Genet. 2008;17(21):3281-90. doi: 10.1093/hmg/ddn224.
33. Zhang Z, Jackson MB. Membrane bending energy and fusion pore kinetics in Ca(2+)-triggered exocytosis. Biophys J. 2010;98(11):2524-34. doi: 10.1016/j.bpj.2010.02.043.
34. Chen XK, Wang LC, Zhou Y, Cai Q, Prakriya M, Duan KL, et al. Activation of GPCRs modulates quantal size in chromaffin cells through G(betagamma) and PKC. Nat Neurosci. 2005;8(9):1160-8. doi: 10.1038/nn1529.
35. Zhang Z, Hui E, Chapman ER, Jackson MB. Regulation of exocytosis and fusion pores by synaptotagmin-effector interactions. Mol Biol Cell. 2010;21(16):2821-31. doi: 10.1091/mbc.E10-04-0285.
36. Calejo AI, Jorgacevski J, Kucka M, Kreft M, Goncalves PP, Stojilkovic SS, et al. cAMP-mediated stabilization of fusion pores in cultured rat pituitary lactotrophs. J Neurosci. 2013;33(18):8068-78. doi: 10.1523/JNEUROSCI.5351-12.2013.
37. Carabelli V, Giancippoli A, Baldelli P, Carbone E, Artalejo AR. Distinct potentiation of L-type currents and secretion by cAMP in rat chromaffin cells. Biophys J. 2003;85(2):1326-37. doi: 10.1016/S0006-3495(03)74567-6.